Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Pain, Postoperative 19Breast Neoplasms 13Brain Neoplasms 11Agnosia 7Neoplasms 6Lung Neoplasms 5Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Pituitary Neoplasms 3Pain 3Inflammation 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Abdominal Neoplasms 2Thrombosis 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1

Interventions

Levetiracetam 6Cannabidiol 5perampanel 2Tranexamic Acid 2Standard of Care 2Everolimus 2ziprasidone 1enzalutamide 1Zolpidem 1Warfarin 1Vigabatrin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Temozolomide 1Spironolactone 1Solutions 1Sodium Chloride 1Sevelamer 1Saline Solution 1Rocuronium 1Remifentanil 1Propofol 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Seizures × Dexmedetomidine × Clear all
NCT05103735 2023-01-31

Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

Azienda Sanitaria-Universitaria Integrata di Udine

Completed
170 enrolled

Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡